Akero Therapeutics’ (AKRO) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Akero Therapeutics (NASDAQ:AKRO – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $40.00 price objective on the stock. HC Wainwright also issued estimates for Akero Therapeutics’ Q4 2023 earnings at ($1.01) EPS, FY2023 earnings at […]
More Stories
Veritex (NASDAQ:VBTX) Stock Passes Below 200 Day Moving Average – Here’s Why
Veritex Holdings, Inc. (NASDAQ:VBTX – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday ....
Proton Motor Power Systems (LON:PPS) Stock Passes Below Two Hundred Day Moving Average – What’s Next?
Proton Motor Power Systems Plc (LON:PPS – Get Free Report)’s stock price passed below its 200-day moving average during trading...
Castings (LON:CGS) Shares Cross Below 200-Day Moving Average – What’s Next?
Castings P.L.C. (LON:CGS – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday ....
iShares MSCI Poland UCITS ETF USD (Acc) (LON:SPOL) Shares Cross Below Two Hundred Day Moving Average – Here’s What Happened
iShares MSCI Poland UCITS ETF USD (Acc) (LON:SPOL – Get Free Report)’s share price crossed below its two hundred day...
Analysts Set Harmonic Inc. (NASDAQ:HLIT) Target Price at $15.25
Harmonic Inc. (NASDAQ:HLIT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six ratings...
Vornado Realty Trust (NYSE:VNO) Receives Consensus Recommendation of “Hold” from Analysts
Vornado Realty Trust (NYSE:VNO – Get Free Report) has been given an average recommendation of “Hold” by the eleven ratings...